Quick Answer
Cordyceps Sunshine Biotech Holdings Co., Ltd. reported Long Term Debt of $431.1 thousand for the year ending 2023.
- Cordyceps Sunshine Biotech Holdings Co., Ltd. showed an increase of +4.1% in Long Term Debt from 2022 to 2023.
- This data is from Cordyceps Sunshine Biotech Holdings Co., Ltd.'s annual report (Form 10-K), filed with the SEC on June 13, 2025.
- XBRL data for this metric is available from 2022 to 2023 (2 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Historical annual values: Fiscal year 2023: $431.1 thousand | Fiscal year 2022: $414.0 thousand.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: